Antioxidants and ischaemic heart disease (vol 350, pg 667, 1997)

被引：0
作者：
Iuliano, L
机构：
来源：
LANCET | 1997年 / 350卷 / 9092期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1712 / 1712
页数：1
相关论文
共 50 条
[31]   Control of tuberculosis by community health workers in Bangladesh (vol 350, pg 169, 1997) [J].
Chowdhury, AMR .
LANCET, 1997, 350 (9084) :1108-1108
[32]   Total cholesterol and risk of mortality in the oldest old (vol 350, pg 1119, 1997) [J].
Weverling-Rijnsburger, AWE .
LANCET, 1998, 351 (9095) :70-70
[33]   Abciximab: an updated review of its use in ischaemic heart disease (vol 56, pg 629, 1998) [J].
Foster, RH ;
Wiseman, LR .
DRUGS, 1999, 57 (01) :91-91
[34]   Evaluating coronary heart disease risk: Tiles in the mosaic (vol 277, pg 1387, 1997) [J].
Hoeg, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (08) :636-636
[35]   Valvular heart disease associated with fenfluramine-phentermine (vol 337, pg 581, 1997) [J].
Connolly, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1783-1783
[36]   Biventricular diverticulosis and rheumatic heart disease: A case report (vol 50, pg 597, 1997) [J].
Beneitez, JF .
REVISTA ESPANOLA DE CARDIOLOGIA, 1997, 50 (10) :708-708
[37]   Homocysteine, lipid indices and antioxidants in patients with ischaemic heart disease from Maharashtra, India [J].
Bhagwat, V. R. ;
Yadav, A. S. ;
Rathod, I. M. .
SINGAPORE MEDICAL JOURNAL, 2009, 50 (04) :418-424
[38]   Orally active prostacyclin analogue in primary pulmonary hypertension (vol 350, pg 1365, 1997) [J].
Okano, Y .
LANCET, 1997, 350 (9088) :1406-1406
[39]   Combination therapies for HIV infection and genomic drug resistance (vol 350, Pg 970, 1997) [J].
Katzenstein, D .
LANCET, 1997, 350 (9092) :1712-1712
[40]   Global assessment of El Nino's disaster burden (vol 350, pg 1435, 1997) [J].
Bouma, MJ .
LANCET, 1998, 351 (9098) :298-298
12345